Should it be the case that the steady decline in β-cell function in type 2 diabetes is attributable to any significant extent to ongoing apoptosis via chronic oxidative stress with no deterioration in β-cell replication, interference with apoptosis by antioxidants might provide a much needed new ancillary approach to conventional treatment that could stabilize β-cell mass.